The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001

Frank Lichtenberg

No 9754, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to control, to an unusually great extent, for the effects of other potential determinants of longevity, e.g. education, income, nutrition, the environment, and lifestyle'. We find that launches of new chemical entities (NCEs) have a strong positive impact on the probability of survival. Launches of (older) drugs that are not NCEs do not increase longevity. NCE launches account for a significant fraction of the long-run increase in longevity in the sample as a whole. Between 1986 and 2000, average life expectancy of the entire population of sample countries increased by almost two years. Our estimates imply that NCE launches accounted for 0.8 years (40%) of the 1986-2000 increase in longevity. The average annual increase in life expectancy of the entire population resulting from NCE launches is .056 years, or 2.93 weeks.

JEL-codes: F00 I12 (search for similar items in EconPapers)
Date: 2003-06
New Economics Papers: this item is included in nep-hea
Note: EH PR
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (14)

Published as Frank R. Lichtenberg, 2005. "The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001," International Journal of Health Care Finance and Economics, vol 5(1), pages 47-73.
Published as Frank Lichtenberg, 2005. "The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001," International Journal of Health Economics and Management, Springer, vol. 5(1), pages 47-73, January.

Downloads: (external link)
http://www.nber.org/papers/w9754.pdf (application/pdf)

Related works:
Journal Article: The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001 (2005)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:9754

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w9754

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().